Guifang Yang
- Molecular Biology
- Oncology top 5%
- Immunology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Chun‐Wei PengZhiling ZhangYan LiLin‐Wei WangJingping YuanXiaoying JiangJiuyang LiuZhigao Xu
- Topics
- Gastric Cancer Management and Outcomes (10 papers)Immunotherapy and Immune Responses (6 papers)Cancer-related Molecular Pathways (5 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- PLoS ONEBiomaterialsHepatology
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Guifang Yang
54 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 119
- Molecular Biology 642
- Oncology 501
- Immunology 299
- Cancer Research 292
- Pulmonary and Respiratory Medicine 199
Countries citing papers authored by Guifang Yang
This map shows the geographic impact of Guifang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifang Yang more than expected).
Fields of papers citing papers by Guifang Yang
This network shows the impact of papers produced by Guifang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifang Yang. The network helps show where Guifang Yang may publish in the future.
Co-authorship network of co-authors of Guifang Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Guifang Yang. A scholar is included among the top collaborators of Guifang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guifang Yang. Guifang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 18 | |
| 3 | 26 | |
| 4 | 17 | |
| 5 | 40 | |
| 6 | 4 | |
| 7 | 8 | |
| 8 | 15 | |
| 9 | 24 | |
| 10 | 17 | |
| 11 | 15 | |
| 12 | Expression and clinical significance of CD44 and nm23-H1proteins in non-small cell lung cancer | 1 |
| 13 | 27 | |
| 14 | 57 | |
| 15 | 29 | |
| 16 | 7 | |
| 17 | 22 | |
| 18 | 65 | |
| 19 | 72 | |
| 20 | 24 |
About Guifang Yang
Guifang Yang is a scholar working on Oncology, Leadership and Management and Issues, ethics and legal aspects, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (10 papers), Immunotherapy and Immune Responses (6 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (292 citations), Oncology (501 citations) and Immunology (299 citations). Guifang Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Chun‐Wei Peng, Zhiling Zhang, Yan Li, Yan Li, Lin‐Wei Wang, Jingping Yuan, Xiaoying Jiang, Jiuyang Liu, Yan Li and Zhigao Xu. Their work appears in journals such as PLoS ONE, Biomaterials and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.